EXASHealthcareLarge-Cap

EXACT SCIENCES CORP Insider Trading Activity

Every SEC Form 4 insider transaction reported for EXACT SCIENCES CORP (EXAS), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are EXAS insiders buying or selling?

EXACT SCIENCES CORP insiders reported 1 open-market buys ($1.0M) and 255 sells ($249.6M) across 256 Form 4 filings — a net selling position of $248.6M.

Source: SEC EDGAR Form 4

Key Statistics (as of Nov 21, 2025)

Total Form 4 filings
256
SEC EDGAR
Insider filers
20
Insider buys (1)
$1.0M
Insider sells (255)
$249.6M

Insider sentiment

Net selling

Net insider flow of $248.6M in net selling.

Recent EXAS insider transactions

DateInsiderRoleTypeSharesPriceValue
Nov 21, 2025Jacob A OrvilleEVP, GM, ScreeningSale5.0K$75.00$375.0K
Nov 21, 2025James HerriottSVP, General Counsel & SecSale1.0K$70.00$70.0K
Nov 6, 2025James HerriottSVP, General Counsel & SecSale1.5K$70.08$105.1K
Nov 6, 2025Brian BaranickEVP, GM, Precision OncologySale2.9K$70.08$200.3K
Oct 28, 2025Katherine S ZanottiDirectorSale12.0K$65.00$780.0K
Oct 10, 2025James HerriottSVP, General Counsel & SecSale1.5K$60.00$90.0K
Oct 10, 2025James Edward DoyleDirectorSale2.0K$60.00$120.0K
Jun 16, 2025Katherine S ZanottiDirectorSale3.2K$53.20$170.6K
Nov 13, 2024Kevin T ConroyPresident and CEOPurchase19.5K$51.35$1.0M
Oct 9, 2024Brian BaranickEVP, GM, Precision OncologySale929$70.00$65.0K
Sep 19, 2024Brian BaranickEVP, GM, Precision OncologySale929$70.00$65.0K
May 2, 2024Scott D CowardDirectorSale67$60.15$4.0K
May 2, 2024Everett CunninghamChief Commercial OfficerSale136$60.15$8.2K
May 2, 2024James HerriottSVP, General Counsel & SecSale30$60.15$1.8K
May 2, 2024Jeffrey Thomas ElliottChief Financial OfficerSale136$60.15$8.2K
May 2, 2024Brian BaranickEVP, GM., Precision OncologySale110$60.15$6.6K
May 2, 2024Sarah CondellaEVP, Human ResourcesSale102$60.15$6.1K
May 2, 2024Jacob A OrvilleGeneral Manager, ScreeningSale102$60.15$6.1K
May 2, 2024Kevin T ConroyPresident and CEOSale1.2K$60.15$69.5K
Apr 3, 2024Sarah CondellaEVP, Human ResourcesSale2.0K$70.00$140.0K
Apr 3, 2024Brian BaranickEVP, GM., Precision OncologySale924$79.43$73.4K
Mar 5, 2024Jacob A OrvilleGeneral Manager, ScreeningSale2.2K$59.32$127.8K
Mar 5, 2024Daniel J LevangieDirectorSale5.0K$57.50$287.5K
Mar 5, 2024James HerriottGeneral CounselSale862$59.32$51.1K
Mar 5, 2024Jeffrey Thomas ElliottChief Financial OfficerSale2.4K$59.32$143.1K

Showing the 25 most recent of 256 Form 4 filings for EXACT SCIENCES CORP.

Most active EXAS insiders

  • Kevin T Conroy47 filings
  • Jeffrey Thomas Elliott30 filings
  • Scott D Coward29 filings
  • Sarah Condella28 filings
  • Jacob A Orville18 filings

Ask anything about EXAS insider activity

Use Trabud's AI agent to query EXACT SCIENCES CORP's Form 4 history in plain English — "Show me EXAS CEO purchases this year" or compare it against any other ticker.

Open the AI agent

EXAS insider trading FAQ

Are EXACT SCIENCES CORP insiders buying or selling?

Across 256 SEC Form 4 filings, EXACT SCIENCES CORP (EXAS) insiders reported 1 open-market purchases totaling $1.0M and 255 sales totaling $249.6M. That is a net selling position of $248.6M.

How many insiders trade EXAS stock?

20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for EXACT SCIENCES CORP. The most recent filing was accepted on Nov 21, 2025.

Where does Trabud get EXAS insider trading data?

All EXAS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content